Clinical outcomes of stereotactic MR-guided adaptive radiation therapy for high-risk lung tumors

Magnetic resonance (MR-)guided stereotactic ablative radiotherapy (SABR) was performed for patients with lung tumors in whom treatment delivery was challenging due to tumor location, motion or pulmonary comorbidity. As stereotactic MR-guided adaptive radiation therapy (or SMART) is a novel approach, we studied clinical outcomes in these high-risk lung tumors.

Source: International Journal of Radiation Oncology * Biology * Physics - February 23, 2020 Category: Radiology Authors: Tobias Finazzi, Cornelis J.A. Haasbeek, Femke O.B. Spoelstra, Miguel A. Palacios, Marjan A. Admiraal, Anna M.E. Bruynzeel, Berend J. Slotman, Frank J. Lagerwaard, Suresh Senan Source Type: research